Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
ABLIM3
Entity type
gene
Source
Source Link
Details
PrimaryID
22885
RefseqGene
NG_051566
Symbol
ABLIM3
Name
actin binding LIM protein family member 3
Chromosome
5
Location
5q32
TaxID
9606
Status
live
SourceGenome
genomic
SourceOrigin
natural
CreationDate
1999-11-30
ModificationDate
2021-06-11
Ontological Relatives
UniProt IDs
ABLM3_HUMAN
GO terms
Show/Hide Table
GO
Name
GO:0001725
stress fiber
GO:0005737
cytoplasm
GO:0006351
transcription, DNA-templated
GO:0015629
actin cytoskeleton
GO:0030027
lamellipodium
GO:0030032
lamellipodium assembly
GO:0030036
actin cytoskeleton organization
GO:0045944
positive regulation of transcription by RNA polymerase II
GO:0046872
metal ion binding
GO:0051015
actin filament binding
GO:0060271
cilium assembly
GO:0098978
glutamatergic synapse
GO:1903955
positive regulation of protein targeting to mitochondrion
Diseases
Show/Hide Table
Interactions
22 interactions
Interactor
Partner
Sources
Publications
Link
ABLIM3
IKZF3
BioGRID, IntAct
25416956
31515488
32296183
details
ABLIM3
SSX2IP
BioGRID, IntAct
25416956
details
ABLIM3
ABI2
BioGRID, IntAct
32296183
details
ABLIM3
SNW1
BioGRID, IntAct
32296183
details
ABLIM3
CWF19L2
BioGRID, IntAct
32296183
details
ABLIM3
CBX8
BioGRID, IntAct
32296183
details
ABLIM3
BANP
BioGRID, IntAct
32296183
details
ABLIM3
TFIP11
BioGRID, IntAct
32296183
details
ABLIM3
HIKESHI
BioGRID, IntAct
32296183
details
ABLIM3
PALMD
BioGRID, IntAct
32296183
details
ABLIM3
CATSPER1
BioGRID, IntAct
32296183
details
ABLIM3
ZNF620
BioGRID, IntAct
32296183
details
ABLIM3
CCDC33
BioGRID, IntAct
25416956
31515488
details
ABLIM3
BRCA1
BioGRID
25184681
details
ABLIM3
ACTC1
BioGRID, HPRD
15337165
details
ABLIM3
ACTA1
BioGRID
17194709
details
ABLIM3
ABRA
BioGRID
17194709
details
ABLIM3
GRB2
IntAct
12577067
details
ABLIM3
MCM7
IntAct
23764002
details
ABLIM3
CDH1
BioGRID
25468996
details
ABLIM3
EGFR
BioGRID
25754235
details
ABLIM3
APEX1
BioGRID
28986522
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree